JPH10245390A5 - - Google Patents

Info

Publication number
JPH10245390A5
JPH10245390A5 JP1997061875A JP6187597A JPH10245390A5 JP H10245390 A5 JPH10245390 A5 JP H10245390A5 JP 1997061875 A JP1997061875 A JP 1997061875A JP 6187597 A JP6187597 A JP 6187597A JP H10245390 A5 JPH10245390 A5 JP H10245390A5
Authority
JP
Japan
Prior art keywords
group
hydroxy
positions
lower alkoxy
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997061875A
Other languages
English (en)
Japanese (ja)
Other versions
JP3536574B2 (ja
JPH10245390A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP06187597A priority Critical patent/JP3536574B2/ja
Priority claimed from JP06187597A external-priority patent/JP3536574B2/ja
Publication of JPH10245390A publication Critical patent/JPH10245390A/ja
Application granted granted Critical
Publication of JP3536574B2 publication Critical patent/JP3536574B2/ja
Publication of JPH10245390A5 publication Critical patent/JPH10245390A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP06187597A 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体 Expired - Fee Related JP3536574B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP06187597A JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06187597A JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003351296A Division JP4155150B2 (ja) 2003-10-09 2003-10-09 抗腫瘍性新規インドロピロロカルバゾール誘導体

Publications (3)

Publication Number Publication Date
JPH10245390A JPH10245390A (ja) 1998-09-14
JP3536574B2 JP3536574B2 (ja) 2004-06-14
JPH10245390A5 true JPH10245390A5 (enExample) 2004-10-14

Family

ID=13183755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP06187597A Expired - Fee Related JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Country Status (1)

Country Link
JP (1) JP3536574B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083228A1 (ja) * 1999-09-10 2004-09-30 Katsuhisa Kojiri インドロピロロカルバゾール誘導体及び抗腫瘍剤
DK1258490T3 (da) 2000-02-24 2004-04-05 Banyu Pharma Co Ltd Fremgangsmåde til fremstilling af indolopyrrolocarbazol, mellemprodukter dertil og fremgangsmåde til fremstillingen af mellemprodukterne
AP2004003120A0 (en) 2002-03-26 2004-09-30 Banyu Pharma Co Ltd Combined use of antitumor indolopyrrolocarbazole derivatives and other antitumor agent
WO2005010017A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd インドロピロロカルバゾール誘導体及び抗腫瘍剤
WO2005010018A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd. 結晶形態の６−ｎ−ピリジルメチルアミノインドロカルバゾール化合物
US20070042975A1 (en) * 2003-09-16 2007-02-22 Koji Yamada Novel indolopyrrolocarbazole derivative with antitumor activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018003A1 (fr) 1990-05-11 1991-11-28 Banyu Pharmaceutical Co., Ltd. Derive antitumoral de be-13793c
WO1995030682A1 (en) 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
AU3086495A (en) 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles

Similar Documents

Publication Publication Date Title
CA2302445A1 (en) New taxane derivatives
RU93043106A (ru) Способ получения производных таксана, производные таксана, фармацевтическая композиция на их основе, способ лечения, производные оксазолидина и способ получения производных оксазолидина
WO2005105152A3 (en) Lipids, lipid complexes and use thereof
RU2002112227A (ru) Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
JP2002332234A5 (enExample)
CA2475113A1 (en) Isothiazole derivatives useful as anticancer agents
JP2002532112A5 (enExample)
RU2000119792A (ru) Моносульфат азепептидного производного и содержащая его фармацевтическая композиция, ингибирующая вич-протеазу
JP2004538039A5 (enExample)
JP2004533444A5 (enExample)
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
CA2378148A1 (en) Nematicidal trifluorobutenes
EP0711768A4 (en) BENZIMIDAZOL DERIVATIVE
JP2002080321A5 (enExample)
RU93055882A (ru) Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе
CA2259977A1 (en) Taxane derivatives and drugs containing the same
CA2415010A1 (en) Propane-1,3-dione derivatives useful as gnrh receptor antagonist
JP2000159790A5 (enExample)
EP0992509A3 (en) Novel macrolide derivatives
CA2673449A1 (en) A combination comprising combretastatin and anticancer agents
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
JPH10245390A5 (enExample)
CA2263353A1 (en) Arylsulfonylimidazolone derivatives as an antitumor agent
JPH09235233A5 (enExample)
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция